Related Experiment Videos
Case report: systemic hypersensitivity reaction to goserelin acetate
S G Raj1, A J Karadsheh, R J Guillot
1Department of Obstetrics and Gynecology, Louisiana State University Medical Center, New Orleans 70112, USA.
The American Journal of the Medical Sciences
|October 1, 1996
Summary
Hypersensitivity reactions, including anaphylaxis, can occur with gonadotropin-releasing hormone (GnRH) analogues like goserelin acetate used for endometriosis. This case highlights a rare anaphylactic event to a goserelin acetate implant.
Area of Science:
- Reproductive Endocrinology
- Clinical Immunology
Background:
- Long-acting gonadotropin-releasing hormone (GnRH) analogues are standard treatments for endometriosis.
- Goserelin acetate implants are commonly prescribed GnRH analogues.
Observation:
- A patient receiving a goserelin acetate implant for endometriosis experienced an adverse event.
- The event presented as a severe hypersensitivity reaction, specifically anaphylaxis.
Findings:
- This case represents the first documented instance of hypersensitivity and anaphylaxis to a goserelin acetate implant.
- The GnRH analogue goserelin acetate was identified as the causative agent.
Implications:
- Clinicians should be aware of the potential for rare anaphylactic reactions to goserelin acetate.
- This finding necessitates vigilance for hypersensitivity in patients treated with GnRH analogues.
- Further investigation into the immunogenicity of GnRH analogues may be warranted.